Geron Corp.

NASDAQ:GERN 4:00:00 PM EDT

3.73

+0.05 (+1.36%)

: $3.78 +0.05 (+1.34%)

Market Cap (Intraday)	2.22B
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.03 Million
Adjusted EPS	-$0.10

See more estimates

10-Day MA	$3.57
50-Day MA	$2.72
200-Day MA	$2.38

See more pivots

Geron Corp. Stock, NASDAQ:GERN

919 East Hillsdale Boulevard, Suite 250, Foster City, California 94404

United States of America

Phone: +1.650.473.7700

Number of Employees: 141

http://www.geron.com

Description

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.